CareDx Inc (CDNA) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 64/100
Alpha Vantage · GuruFocus · · AI-summarised by FinFlash
CareDx Inc (CDNA) shares increased by 3.7% to $65.43, but GuruFocus's GF Value assesses the stock as 156.0% overvalued with an intrinsic value of $25.56. The company has a GF Score of 64/100, indicating above-average performance, but faces concerns regarding profitability, valuation, and significant insider selling.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.